This work shows that the H4K20 monomethyltransferase KMT5A sustains canonical Notch signaling in quiescent MuSCs through catalytic deposition of H4K20me1, indicating that H4K20me1 supports transcriptional competence at Notch loci.
Abstract
Summary Quiescence preserves muscle stem cell (MuSC) identity and regenerative capacity, but the chromatin mechanisms that support this state remain incompletely understood. Here, we show that the H4K20 monomethyltransferase KMT5A sustains canonical Notch signaling in quiescent MuSCs through catalytic deposition of H4K20me1. Loss of Kmt5a led to delayed reduction of Rbpj and other canonical Notch pathway genes, whereas acute catalytic inhibition of KMT5A was sufficient to suppress their expression, indicating that H4K20me1 supports transcriptional competence at Notch loci. Genetic restoration of Notch signaling rescued quiescence-associated features in Kmt5a-deficient MuSCs but did not restore post-activation survival or regenerative output. During physiological activation after injury, H4K20me1 at Notch loci remained largely preserved while H4K20me3 accumulated. Together, these findings identify KMT5A-dependent H4K20me1 as a chromatin mechanism that maintains the Notch-dependent quiescence program and distinguish homeostatic Kmt5a loss from physiological MuSC activation.
A TCF3-lysosome regulatory axis is established that actively safeguards MuSC quiescence, prevents premature stem cell exhaustion, and sustains regenerative competence across repeated tissue injuries.
Yuan-Yuan Guo, Wen-Xiang Ma, Chao Qi et al.· Cell Death & Disease· 0 citations
Histone 3 lysine 27-to-methionine substitutions (H3K27M) drive aggressive diffuse midline gliomas by blocking differentiation of radial glial progenitor cells committed to oligodendrogenesis. We establish prolonged differentiation as a powerful tool to uncover regulators of glioma cell states and demonstrate that t...
Alan L. Jiao, Abolfazl Maghrouni, A. Gutiérrez et al.· Nature Communications· 0 citations
Molecular, cellular, and niche-level evidence across these settings are integrated to explain why FGF signaling produces divergent outcomes and to clarify how cellular context and timing should inform therapeutic modulation.
Progenitor cells must proliferate to expand the cell population, yet terminal differentiation requires this proliferative state to end. How signaling controls the duration of this proliferative window remains poorly understood. Using adipogenesis and live single-cell imaging of differentiation, cell-cycle, and ERK-acti...
Sanjeev Sharma, Henri Berger, Zhi-Bo Zhang et al.· bioRxiv· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.